CBOE GLOBAL MARKETS : Can-Fite BioPharma Highlights Is Conducting Preparatory Work For Planned Pivotal Phase III Study Of Namodenoson In Treatment Of Advanced Live Cancer

Press/Media

Period6 May 2019

Media coverage

1

Media coverage